Molecular Pathology & Genomics

Prostate cancer genetics study shows disparities

Risk of prostate cancer is about 75% higher, and more than twice as deadly, in men of African ancestry compared with men of European ancestry.

The British Journal of Biomedical Science: Issue 1 2021, synopsis

Deputy Editor Anthony Rhodes provides a brief glimpse of the articles on offer in the first issue of 2021.

The big question: molecular diagnostics

“Do you think the more we edge towards molecular diagnostics, the higher the likelihood that we will see biomedical science disciplines phased out in the future?”

Lab-on-a-chip for PCR

A new lab-on-a-chip infection test could provide cheaper, faster portable diagnostics, it is claimed.

National Genomic Research Library grows to over 110,000

The National Genomic Research Library (NGRL) now contains one of the richest genomic datasets in the world for both rare disease and cancer research.

NHS to pilot potentially revolutionary blood test

A blood test that may spot more than 50 types of cancer will be piloted by the NHS in a world-leading programme.

Target for aggressive form of lung cancer

Scientists have reported new findings about a particularly aggressive subset of lung adenocarcinomas that are driven by two mutations that frequently occur together in the genes KEAP1 and STK11.

Certificate of Expert Practice - apply now

Applications are open for the Certificate of Expert Practice (CEP) online courses in leadership and management, quality management, molecular pathology, point-of-care testing (POCT), and training, which will commence in January 2021. 

New biomarker for stroke severity

A biomarker in the blood may determine the extent of brain injury from different types of strokes

Genetic risk for IBD patients

In a retrospective study, investigators found that a combination of rare and common genetic variants in some inflammatory bowel disease (IBD) patients significantly increased their risk of developing clot-causing thromboembolic diseases.

Top